CORRELATION OF CIRCULATING EPSTEIN‐BARR VIRUS‐TARGETED CYTOTOXIC T LYMPHOCYTE PRECURSORS (EBV‐CTLp) AND CLINICAL RESPONSE FOLLOWING TABELECLEUCEL (TAB‐CEL) INFUSION IN PATIENTS WITH EBV‐DRIVEN DISEASE. (12th June 2019) - Aftab, B.; Munson, D.; Rasor, K.; Foubert, P.; Tsai, D.; Kai Weng, W.; Ghobadi, A.; van Besien, K.; Sun, Y.; Hiremath, M.; Navarrow, W.; Prockop, S.